IRIS
DI PASQUA, LAURA GIUSEPPINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.428
EU - Europa 801
AS - Asia 455
AF - Africa 5
SA - Sud America 2
Totale 2.691
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.414
IE - Irlanda 412
CN - Cina 369
FI - Finlandia 90
DE - Germania 83
IT - Italia 83
SG - Singapore 53
BE - Belgio 29
SE - Svezia 28
UA - Ucraina 28
CZ - Repubblica Ceca 25
JP - Giappone 20
CA - Canada 14
GB - Regno Unito 13
IN - India 6
FR - Francia 4
EG - Egitto 3
IL - Israele 2
IR - Iran 2
AL - Albania 1
AT - Austria 1
BR - Brasile 1
KR - Corea 1
LT - Lituania 1
LV - Lettonia 1
MU - Mauritius 1
PE - Perù 1
PH - Filippine 1
RO - Romania 1
RU - Federazione Russa 1
VN - Vietnam 1
ZA - Sudafrica 1
Totale 2.691
Salva come PNG Salva come JPEG
Città #
Chandler 455
Dublin 410
Boardman 86
Beijing 80
Helsinki 74
Ashburn 73
Shanghai 68
Princeton 65
Lawrence 63
Medford 61
Jacksonville 49
Nanjing 49
Wilmington 44
Singapore 43
Ann Arbor 38
Pavia 38
Brussels 29
Hebei 25
Munich 22
Brno 21
Changsha 20
Nanchang 20
Tokyo 20
Hangzhou 15
New York 14
Shenyang 13
Toronto 13
Jiaxing 11
Monza 10
Tianjin 10
Los Angeles 9
Seattle 9
Berlin 7
Des Moines 7
Fairfield 7
Falls Church 7
Milan 7
Dallas 6
Houston 6
Falkenstein 5
Raleigh 5
Redwood City 5
Washington 5
Brdo 4
Cagliari 4
Dearborn 4
Guangzhou 4
Laurel 4
Alexandria 3
Brescia 3
Chicago 3
Verona 3
Andover 2
Florence 2
Fuzhou 2
Genoa 2
Kunming 2
Menlo Park 2
New Delhi 2
Ningbo 2
Orange 2
Pune 2
Rockville 2
Santa Clara 2
Shenzhen 2
Woodbridge 2
Xi'an 2
Bovisio Masciago 1
Cambridge 1
Cesena 1
Chengdu 1
Clearwater 1
Dalian 1
Frankfurt am Main 1
General Trias 1
Giussano 1
Giza 1
Guiyang 1
Gunzenhausen 1
Haifa 1
Harbin 1
Jerusalem 1
Jinan 1
Leawood 1
Lima 1
Littleton 1
London 1
Melegnano 1
Naples 1
Ottawa 1
Paris 1
Qingdao 1
Qujing 1
Riga 1
Rome 1
San Francisco 1
Southend 1
Tangjin 1
Tangshan 1
Timisoara 1
Totale 2.119
Salva come PNG Salva come JPEG
Nome #
Changes in ADMA/DDAH pathway after hepatic ischemia/reperfusion injury in rats: the role of bile. 105
Changes in serum levels of asymmetric-dimethylarginine (ADMA) in a rat model of non-alcoholic steatohepatitis: Role of oxidative stress 92
Metabolic shift in liver: correlation between perfusion temperature and hypoxia inducible factor-1α. 79
Lobe-specific heterogeneity in asymmetric dimethylarginine and matrix metalloproteinase levels in a rat model of obstructive cholestasis. 61
Fluorescing fatty acids in rat fatty liver models 61
Animal Models of Steatosis (NAFLD) and Steatohepatitis (NASH) Exhibit Hepatic Lobe-Specific Gelatinases Activity and Oxidative Stress 61
Autofluorescence discrimination of metabolic fingerprint in nutritional and genetic fatty liver models 60
Associations between serum trace elements and inflammation in two animal models of nonalcoholic fatty liver disease 59
Increase in transporter MATE-1 expression induced by obeticholic acid correlates with higher biliary excretion of asymmetric dimethylarginine during hepatic ischemia/reperfusion injury 58
Fatty liver oxidative events monitored by autofluorescence optical diagnosis: Comparison between subnormothermic machine perfusion and conventional cold storage preservation 58
Liver graft susceptibility during static cold storage and dynamic machine perfusion: DCD versus fatty livers 57
Changes in biliary levels of arginine and its methylated derivatives after hepatic ischaemia/reperfusion 56
Immobilized amyloid Aβ peptides support platelet adhesion and activation 55
Comparison between Lipofectamine RNAiMAX and GenMute transfection agents in two cellular models of human hepatoma 55
Nonalcoholic fatty liver disease and non-alcoholic steatohepatitis: Current issues and future perspectives in preclinical and clinical research 53
Selective blockade of the metabotropic glutamate receptor mGluR5 protects mouse livers in in vitro and ex vivo models of ischemia reperfusion injury 50
Liver plays a central role in asymmetric dimethylarginine-mediated organ injury 49
Long-term cold storage preservation does not affect fatty livers from rats fed with a methionine and choline deficient diet 49
Localization and role of metabotropic glutamate receptors subtype 5 in the gastrointestinal tract 48
Oxygen tension-independent protection against hypoxic cell killing in rat liver by low sodium 48
The farnesoid X receptor agonist obeticholic acid upregulates biliary excretion of asymmetric dimethylarginine via MATE-1 during hepatic ischemia/reperfusion injury 48
Isolation of rat hepatocytes for pharmacological studies on metabotropic glutamate receptor (mGluR) subtype 5: a comparison between collagenase I versus collagenase IV. 47
Serum and hepatic autofluorescence as a real-time diagnostic tool for early cholestasis assessment 46
Fatty acid desaturase involvement in non-alcoholic fatty liver disease rat models: Oxidative stress versus metalloproteinases 46
Detailed Molecular Mechanisms Involved in Drug-Induced Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis: An Update 44
Fatty liver susceptibility to preservation injury using static cold storage versus dynamic machine perfusion 43
Obeticholic acid reduces biliary and hepatic matrix metalloproteinases activity in rat hepatic ischemia/reperfusion injury 39
Alterations in stearoyl-CoA-desaturase index and metalloproteinase activity in nutritional versus genetic rat models of NAFLD 39
SAT-389-Obeticholic acid reduces matrix metalloproteinases activity via iNOS modulation in hepatic ischemia/reperfusion injury 38
The FXR agonist obeticholic acid decreases matrix metalloproteinase activity via RECK and TIMP modulation in hepatic ischemia/reperfusion injury 38
The selective blockade of metabotropic glutamate receptor-5 attenuates fat accumulation in an in vitro model of benign steatosis 37
Analysis of Massaciuccoli Peat after Maturation in Sodium Chloride Water of Undulna Thermae 37
Obeticholic Acid Reduces Kidney Matrix Metalloproteinase Activation Following Partial Hepatic Ischemia/Reperfusion Injury in Rats 36
Hepatic ischemia induces a time-dependent increase in SERPINB3 gene expression 36
Fluorescence excitation properties of bilirubin in solution and in serum 36
MicroCT evaluation of low-density segmented volume in II, IV and VII-week MCD rats 34
Obeticholic acid restores hepatic RECK content in a diet-induced ob/ob mouse model of NASH 34
P0006 : Hepatic ischemia/reperfusion induces changes in tissue and biliary levels of arginine and its methylated derivatives 34
Allosteric modulation of mGlu5 receptors by MPEP protects against hepatic cold ischemia and reperfusion injury 34
Liver injury and changes in biliary, tissue and serum levels of Asymmetric Dimethylarginine: role of Obeticholic Acid, a Farnesoid X Receptor agonist. 33
Cold ischemic injury is reduced by the mGluR5 negative allosteric modulator MPEP in rat livers from cardiac death donors 32
INOS-mediated decrease of matrix metalloproteinase activity by obeticholic acid in hepatic ischemia/reperfusion 32
Hepatic ischemic injury decreases using negative allosteric modulators of metabotropic glutamate receptor subtype 5 32
Hepatic ischemia induces a time-dependent increase in SerpinB3 gene expression 31
Negative allosteric modulators of metabotropic glutamate receptor subtype 5 protect against hepatic ischemia/reperfusion injury 31
The Farnesoid-X-Receptor Agonist Obeticholic Acid Further Increases Biliary Excretion of Asymmetric Dimethylarginine during Hepatic Ischemia/Reperfusion Injury 30
Further increase in biliary excretion of asymmetric dimethylarginine during hepatic ischemia/reperfusion injury by obeticholic acid, a farnesoid-X-receptor agonist 30
Obeticholic acid reduces hepatic matrix metalloproteinase activity in a diet-induced ob/ob mouse model of NASH 29
RECK- and TIMP-mediated downregulation of matrix metalloproteinase activity by obeticholic acid in hepatic ischemia/reperfusion 29
NAD(P)H and Flavin Autofluorescence Correlation with ATP in Rat Livers with Different Metabolic Steady-State Conditions 29
Lobe-specific oxidative stress and matrix metalloproteinase activation in two animal models of non-alcoholic fatty liver disease (NAFLD) 29
OCA administration reduces lung matrix metalloproteinase activation following hepatic ischemia/reperfusion injury in rats 29
Upregulation of MATE-1 transporter by obeticholic acid correlates with increased biliary excretion of asymmetric dimethylarginine during hepatic ischemia/reperfusion injury 29
Selective Blockade of Metabotropic Glutamate Receptor by MPEP Protects against Hepatic Cold Ischemia and Reperfusion Injury 29
Spectrofluorometric analysis of autofluorescing components of crude serum from a rat liver model of ischemia and reperfusion 27
Metabotropic glutamate receptor blockade reduces preservation damage in livers from donors after cardiac death 27
Autofluorescence detection of liver oxidative damage products 27
Changes in glutathione content in liver diseases: An update 26
Oxidative stress, mitochondria damage and matrix metalloprotease activation in the pathogenesis of NAFLD 25
Machine perfusion at 20°C prevents ischemic injury and reduces hypoxia-inducible factor-1α expression during rat liver preservation 25
MCD diet-induced steatohepatitis is associated with alterations in asymmetric dimethylarginine (ADMA) and its transporters 24
MPEP administration reduces steatosis and inflammation in ob/ob mice 24
Patient-derived liver organoids as an in vitro model to study new personalized therapies targeting VDAC1 in intrahepatic cholangiocarcinoma 20
Transient Expression of Reck Under Hepatic Ischemia/Reperfusion Conditions Is Associated with Mapk Signaling Pathways 20
Innovative targets involved in the progression of NASH: Asymmetric-dymethylarginine (ADMA) and its cationic transporters 19
Obeticholic acid reduces lipid accumulation and fibrosis in a diet-induced ob/ob mouse model of NASH 17
Mitochondrial Complex I modulator (CIM) reduces lipid accumulation and inflammation in MCD-diet fed rats 17
Fatty Acids and Bilirubin as Intrinsic Autofluorescence Serum Biomarkers of Drug Action in a Rat Model of Liver Ischemia and Reperfusion 16
Metalloproteinases activation involvement in the progression of liver injury from NAFLD to NASH 16
MPEP Attenuates Intrahepatic Fat Accumulation in Obese Mice 15
SerpinB3 administration protects liver against ischemia-reperfusion injury 12
FXR agonists INT-787 and OCA increase RECK and inhibit liver steatosis and inflammation in diet-induced ob/ob mouse model of NASH 12
MCD Diet Rat Model Induces Alterations in Zinc and Iron during NAFLD Progression from Steatosis to Steatohepatitis 12
Venetoclax-Related Neutropenia in Leukemic Patients: A Comprehensive Review of the Underlying Causes, Risk Factors, and Management 9
Targeting mitochondrial complex I modulates lipid metabolism, inflammation and hepatic fibrosis in a MCD-diet model of benign steatosis 9
MCD Diet Modulates HuR and Oxidative Stress-Related HuR Targets in Rats 6
Recent Updates on the Therapeutic Prospects of Reversion-Inducing Cysteine-Rich Protein with Kazal Motifs (RECK) in Liver Injuries 2
Totale 2.821
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.623
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.623
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020100 0 0 0 0 0 8 6 5 1 40 37 3
2020/2021116 6 5 3 5 0 20 18 23 13 12 9 2
2021/2022325 2 3 4 3 7 6 4 26 5 11 101 153
2022/20231.207 138 112 12 136 59 128 1 58 489 12 49 13
2023/2024480 78 54 23 24 39 83 49 30 1 20 31 48
2024/2025266 26 86 22 21 20 91 0 0 0 0 0 0
Totale 2.821